| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.00097 | 1 |